{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T08:03:59Z","timestamp":1793865839235,"version":"4.6.1"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2018,4,24]],"date-time":"2018-04-24T00:00:00Z","timestamp":1524528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/about_us\/legal\/notices"}],"funder":[{"name":"Kamin Fund of the Israel Ministry of Trade and Industry","award":["56136"],"award-info":[{"award-number":["56136"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,8,1]]},"DOI":"10.1093\/rheumatology\/key092","type":"journal-article","created":{"date-parts":[[2018,3,22]],"date-time":"2018-03-22T20:10:39Z","timestamp":1521749439000},"page":"1472-1480","source":"Crossref","is-referenced-by-count":19,"title":["Inhibition of nucleotide pyrophosphatase\/phosphodiesterase 1: implications for developing a calcium pyrophosphate deposition disease modifying drug"],"prefix":"10.1093","volume":"57","author":[{"given":"Ortal","family":"Danino","sequence":"first","affiliation":[{"name":"Department of Chemistry, Bar-Ilan University, Ramat-Gan, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuli","family":"Svetitsky","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Kenigsberg","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Bar-Ilan University, Ramat-Gan, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asaf","family":"Levin","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Bar-Ilan University, Ramat-Gan, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shani","family":"Journo","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aviram","family":"Gold","sequence":"additional","affiliation":[{"name":"Division of Orthopedics, Tel Aviv Medical Center and the Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Drexler","sequence":"additional","affiliation":[{"name":"Division of Orthopedics, Tel Aviv Medical Center and the Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nimrod","family":"Snir","sequence":"additional","affiliation":[{"name":"Division of Orthopedics, Tel Aviv Medical Center and the Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ori","family":"Elkayam","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilha","family":"Fischer","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Bar-Ilan University, Ramat-Gan, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uri","family":"Arad","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,4,24]]},"reference":[{"key":"key\n\t\t\t\t20180723035921_key092-B1","first-page":"32","article-title":"Update on calcium pyrophosphate deposition","volume":"34","author":"Abhishek","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"key\n\t\t\t\t20180723035921_key092-B2","first-page":"S31","article-title":"Measuring functional disability in early rheumatoid arthritis: the validity, reliability and responsiveness of the Recent-Onset Arthritis Disability (ROAD) index","volume":"23(5 Suppl 39)","author":"Salaffi","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"key\n\t\t\t\t20180723035921_key092-B3","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1136\/ard.2010.139105","article-title":"European League Against Rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosis","volume":"70","author":"Zhang","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t20180723035921_key092-B4","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1186\/s13075-014-0458-4","article-title":"Methotrexate in chronic-recurrent calcium pyrophosphate deposition disease: no significant effect in a randomized crossover trial","volume":"16","author":"Finckh","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"key\n\t\t\t\t20180723035921_key092-B5","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.joca.2008.05.020","article-title":"Inorganic pyrophosphate as a regulator of hydroxyapatite or calcium pyrophosphate dihydrate mineral deposition by matrix vesicles","volume":"17","author":"Thouverey","year":"2009","journal-title":"Osteoarthritis Cartilage"},{"key":"key\n\t\t\t\t20180723035921_key092-B6","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/10409230091169249","article-title":"Nucleotide pyrophosphatases\/phosphodiesterases on the move","volume":"35","author":"Bollen","year":"2000","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"key\n\t\t\t\t20180723035921_key092-B7","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1074\/jbc.M007552200","article-title":"Structural and catalytic similarities between nucleotide pyrophosphatases\/phosphodiesterases and alkaline phosphatases","volume":"276","author":"Gijsbers","year":"2001","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20180723035921_key092-B8","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0140-6736(70)92070-2","article-title":"Inorganic pyrophospate in plasma, urine, and synovial fluid of patients with pyrophosphate arthropathy (chondrocalcinosis or pseudogout)","volume":"296","author":"Russell","year":"1970","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180723035921_key092-B9","first-page":"716","article-title":"Synovial fluid ATP: a potential substrate for the production of inorganic pyrophosphate","volume":"18","author":"Ryan","year":"1991","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t20180723035921_key092-B10","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/ard.50.4.214","article-title":"Synovial fluid pyrophosphate and nucleoside triphosphate pyrophosphatase: comparison between normal and diseased and between inflamed and non-inflamed joints","volume":"50","author":"Pattrick","year":"1991","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t20180723035921_key092-B11","first-page":"1275","article-title":"Differential effects of aging on human chondrocyte responses to transforming growth factor beta: increased pyrophosphate production and decreased cell proliferation","volume":"40","author":"Rosen","year":"1997","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20180723035921_key092-B12","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1186\/ar4453","article-title":"The association between ANKH promoter polymorphism and chondrocalcinosis is independent of age and osteoarthritis: results of a case-control study","volume":"16","author":"Abhishek","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"key\n\t\t\t\t20180723035921_key092-B13","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1086\/343054","article-title":"Mutations in ANKH cause chondrocalcinosis","volume":"71","author":"Pendleton","year":"2002","journal-title":"Am J Hum Genet"},{"key":"key\n\t\t\t\t20180723035921_key092-B14","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/1529-0131(200105)44:5<1071::AID-ANR187>3.0.CO;2-3","article-title":"Up-regulated expression of the phosphodiesterase nucleotide pyrophosphatase family member PC-1 is a marker and pathogenic factor for knee meniscal cartilage matrix calcification","volume":"44","author":"Johnson","year":"2001","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20180723035921_key092-B15","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1002\/1529-0131(199909)42:9<1986::AID-ANR26>3.0.CO;2-O","article-title":"Differential mechanisms of inorganic pyrophosphate production by plasma cell membrane glycoprotein-1 and B10 in chondrocytes","volume":"42","author":"Johnson","year":"1999","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20180723035921_key092-B16","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1073\/pnas.95.6.3094","article-title":"Chondrocyte-derived apoptotic bodies and calcification of articular cartilage","volume":"95","author":"Hashimoto","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20180723035921_key092-B17","doi-asserted-by":"crossref","first-page":"10364","DOI":"10.1073\/pnas.92.22.10364","article-title":"Interleukin 1 beta suppresses transforming growth factor-induced inorganic pyrophosphate (PPi) production and expression of the PPi-generating enzyme PC-1 in human chondrocytes","volume":"92","author":"Lotz","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20180723035921_key092-B18","doi-asserted-by":"crossref","first-page":"9445","DOI":"10.1073\/pnas.142063399","article-title":"Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization","volume":"99","author":"Hessle","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20180723035921_key092-B19","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1359\/jbmr.2003.18.6.994","article-title":"Linked deficiencies in extracellular PPi and osteopontin mediate pathologic calcification associated with defective PC-1 and ANK expression","volume":"18","author":"Johnson","year":"2003","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t20180723035921_key092-B20","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1359\/jbmr.091023","article-title":"Kinetic analysis of substrate utilization by native and TNAP-, NPP1-, or PHOSPHO1-deficient matrix vesicles","volume":"25","author":"Ciancaglini","year":"2010","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t20180723035921_key092-B21","doi-asserted-by":"crossref","first-page":"8485","DOI":"10.1021\/jm100597c","article-title":"Diadenosine 5\u2032,5\u2032\u2032-(boranated)polyphosphonate analogues as selective nucleotide pyrophosphatase\/phosphodiesterase inhibitors","volume":"53","author":"Eliahu","year":"2010","journal-title":"J Med Chem"},{"key":"key\n\t\t\t\t20180723035921_key092-B22","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1021\/jm500196c","article-title":"Highly potent and selective ectonucleotide pyrophosphatase\/phosphodiesterase I inhibitors based on an adenosine 5\u2032-(\u03b1 or \u03b3)-thio-(\u03b1,\u03b2- or \u03b2,\u03b3)-methylenetriphosphate scaffold","volume":"57","author":"Nadel","year":"2014","journal-title":"J Med Chem"},{"key":"key\n\t\t\t\t20180723035921_key092-B23","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1093\/clinchem\/21.10.1383","article-title":"Determination of phosphodiesterase I activity in human blood serum","volume":"21","author":"Hynie","year":"1975","journal-title":"Clin Chem"},{"key":"key\n\t\t\t\t20180723035921_key092-B24","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ab.2004.02.002","article-title":"An Alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction","volume":"329","author":"Gregory","year":"2004","journal-title":"Analytical Biochem"},{"key":"key\n\t\t\t\t20180723035921_key092-B25","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1186\/ar561","article-title":"Tissue engineering: chondrocytes and cartilage","volume":"4","author":"Hardingham","year":"2002","journal-title":"Arthritis Res"},{"key":"key\n\t\t\t\t20180723035921_key092-B26","doi-asserted-by":"crossref","first-page":"24389","DOI":"10.1074\/jbc.271.40.24389","article-title":"Gamma-phosphate-substituted 2\u2032-deoxynucleoside 5\u2032-triphosphates as substrates for DNA polymerases","volume":"271","author":"Arzumanov","year":"1996","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20180723035921_key092-B27","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.ejmech.2008.07.015","article-title":"Identification of hydrolytically stable and selective P2Y1 receptor agonists","volume":"44","author":"Eliahu","year":"2009","journal-title":"Eur J Med Chem"},{"key":"key\n\t\t\t\t20180723035921_key092-B28","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1002\/art.1780351216","article-title":"ATP-induced chondrocalcinosis","volume":"35","author":"Ryan","year":"1992","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20180723035921_key092-B29","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.joca.2008.03.019","article-title":"Characterization of articular calcium-containing crystals by synchrotron FTIR","volume":"16","author":"Rosenthal","year":"2008","journal-title":"Osteoarthritis Cartilage"},{"key":"key\n\t\t\t\t20180723035921_key092-B30","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3899\/jrheum.080528","article-title":"Dexamethasone promotes calcium pyrophosphate dihydrate crystal formation by articular chondrocytes","volume":"36","author":"Fahey","year":"2009","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t20180723035921_key092-B31","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/956","article-title":"Mutation in Npps in a mouse model of ossification of the posterior longitudinal ligament of the spine","volume":"19","author":"Okawa","year":"1998","journal-title":"Nat Genet"},{"key":"key\n\t\t\t\t20180723035921_key092-B32","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/ng1221","article-title":"Mutations in ENPP1 are associated with \u2018idiopathic\u2019 infantile arterial calcification","volume":"34","author":"Rutsch","year":"2003","journal-title":"Nat Genet"},{"key":"key\n\t\t\t\t20180723035921_key092-B33","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1242\/dmm.017905","article-title":"Deficiency of the bone mineralization inhibitor NPP1 protects mice against obesity and diabetes","volume":"7","author":"Huesa","year":"2014","journal-title":"Dis Model Mech"},{"key":"key\n\t\t\t\t20180723035921_key092-B34","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1164\/rccm.201008-1267OC","article-title":"Denufosol tetrasodium in patients with cystic fibrosis and normal to mildly impaired lung function","volume":"183","author":"Accurso","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"key\n\t\t\t\t20180723035921_key092-B35","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.bcp.2011.03.027","article-title":"The clinical potential of the acyclic (and cyclic) nucleoside phosphonates: the magic of the phosphonate bond","volume":"82","author":"De Clercq","year":"2011","journal-title":"Biochem Pharmacol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/57\/8\/1472\/25193853\/key092.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T06:52:25Z","timestamp":1719903145000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/57\/8\/1472\/4984512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,24]]},"references-count":35,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2018,4,24]]},"published-print":{"date-parts":[[2018,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/key092","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,8]]},"published":{"date-parts":[[2018,4,24]]}}}